PAN joins Alliance for Connected Care urging extension on DEA telemedicine flexibilities
During our transition, where to find information about:
- Our merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
The PAN Foundation joined more than 300 healthcare and health advocacy organizations in a letter urging Congress to ensure ongoing access to virtual prescribing for patients and providers of certain controlled substances. The Drug Enforcement Administration (DEA) is anticipated to dramatically limit virtual prescribing, either through new regulations or by allowing the existing flexibilities to expire. Telehealth flexibility has been essential in ensuring that patients receive timely and necessary care. Continuing these practices is vital to sustaining access to treatment and addressing the ongoing health care challenges, particularly in underserved areas.
Read the news release by Alliance for Connected Care